Susquehanna International Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $925K | Sell |
|
|||||
|
2025
Q1 | $515K | Buy |
|
|||||
|
2024
Q4 | $240K | Sell |
|
|||||
|
2024
Q3 | $357K | Sell |
|
|||||
|
2024
Q2 | $939K | Buy |
|
|||||
|
2024
Q1 | $698K | Sell |
|
|||||
|
2023
Q4 | $1.79M | Buy |
|
|||||
|
2023
Q3 | $439K | Buy |
|
|||||
|
2023
Q2 | $391K | Sell |
|
|||||
|
2023
Q1 | $1.71M | Buy |
|
|||||
|
2022
Q4 | $1.42M | Sell |
|
|||||
|
2022
Q3 | $3.35M | Buy |
|
|||||
|
2022
Q2 | $315K | Sell |
|
|||||
|
2022
Q1 | $1.07M | Sell |
|
|||||
|
2021
Q4 | $2.11M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.72M | Buy |
|